MissionIR Articles
-
MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Rebrands with New Name, Ticker to Focus on New Business
Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, has announced that effective today it has changed its name to Safety Shot; its ticker will also change to SHOT. The changes come after the company acquired Safety Shot, the first patented beverage that helps a person feel better faster by reducing blood alcohol content while also boosting…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases. The company today announced its entry into a definitive agreement for the purchase and sale of 1,146,552 of the company’s American Depositary Shares (“ADSs”) (or…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to improve public safety across the U.S. utilizing Amazon.com Inc.’s (NASDAQ: AMZN) Amazon Web Services (“AWS”). The announcement reads, “In Huntington Park, California, Knightscope’s K5 Autonomous Security Robot (‘ASR’) helped reduce calls for service by 10%…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) CEO Spotlighted in Recent ‘Bloomberg Technology’ Segment
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the “Bloomberg Technology” daily news program earlier this week. During the insightful interview, D-Wave Quantum CEO Alan Baratz talked with host Ed Ludlow about the future of quantum computing, noting that quantum computing has the potential to transform how…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Upcoming Destinations for 2023 Strikingly Different EV Experience
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing new stops on its 2023 Strikingly Different EV U.S. tour. This month the EV experience will be in North Carolina as well as Washington, D.C., Philadelphia, New York City and Boston. This year’s Strikingly Different tour began in August, with its first stop…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Collaborates to Unlock the Value of Brands Through Strategic Acquisitions
Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced the acquisition of BlueSky Wellness Inc., along with its portfolio of brands, which adds psychotropic products to its catalog and expands its footprint into the global wellness market. BlueSky wellness-focused ecommerce brands include…
-
MissionIRNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Represents Commitment to Safeguard User Privacy with Announcement of New Position
Near Intelligence (NASDAQ: NIR), a data intelligence platform that curates one of the world’s largest sources of intelligence on people and places, has appointed current general counsel Jay Angelo as its new chief privacy officer; Angelo will continue to serve as general counsel as well. According to the announcement, the appointment of seasoned professional Angelo indicates…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with continued listed standards and anticipated next steps to maintain its listing on the Nasdaq Capital Market. As previously announced, Nemaura was notified…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study
Scinai Immunotherapeutics(NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is reporting encouraging results from its preclinical study of Scinai’s anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis. According to the report, study results suggest…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Superior Coherence Performance with Fluxonium Qubits
D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has announced notable progress in its development of high coherence qubits. D-Wave has designed, manufactured and operated fluxonium qubits that have demonstrated quantum properties that are comparable to the best seen to date in…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Unveils Grant Program to Ensure School Safety
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced the launch of its School Safety Grant Program. According to the announcement, Knightscope’s program makes the safety of schools, children and teachers a top priority and is designed to empower individuals and promote safer learning environments in…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Announces Acquisition of BlueSky Wellness, Expands Footprint in Global Wellness Market
Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery and manufacturing of psychotropic products, is acquiring BlueSky Wellness Inc. and the BlueSky portfolio of brands. According to the announcement, the acquisition adds psychotropic products to the company’s catalog, enabling LSDI to expand its footprint in the global wellness market.…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) to Acquire BlueSky Wellness Inc. in All-Stock Transaction
Lucy Scientific Discovery (NASDAQ: LSDI) is the leader in the psychotropic industry, which recently celebrated the acquisition of the intellectual property of High Times, the most iconic brand in the cannabis industry. Today the company announced an agreement to acquire BlueSky Wellness Inc. and its portfolio of brands, expanding Lucy’s footprint into the growing global…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Acquisition of Romeo Power Assets
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its purchase of battery pack production assets from Romeo Power for approximately $3.5 million. According to the announcement, the deal includes equipment, inventory and intellectual property for high volume EV battery pack and module production. The assets include production lines for EV pack…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation in H.C. Wainwright, LSX USA Congress 2023 and Upcoming Conferences
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company formerly known as BiondVax Pharmaceuticals Ltd., today announced that its CEO Amir Reichman and Chairman of the Board Mark Germain will be attending the H.C. Wainwright 25th Annual Global Investment Conference in New York today and tomorrow (Sept. 11 and 12) and the LSX USA Congress 2023 in…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthening Position in Projected $51B Global Cannabis Market
Lucy Scientific Discovery (NASDAQ: LSDI) is featured in a recent FinancialNewsMedia (“FNM”) Editorial. The editorial provides an overview of LSDI’s position in a global cannabis market projected to hit $51 billion this year. According to the press release, the global cannabis market has seen consistent growth year after year, with increasing legalization of cannabis fueling…
-
MissionIRNewsBreaks – Eloro Resources Ltd.’s (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Recent Models Suggest Potential Access to High-Grade Deposit
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, is now embarked on the process of finalizing the release of its initial mineral resource estimate (“MRE”) report, which will seek to provide the market with further granularity as to the Iska Iska property’s viability as a commercial mining operation going forward.…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASRs for New Client, 2nd-Year Contract Renewal
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another new deployment and contract renewal for K5 ASRs. The announcement reads, “Knightscope’s commitment to making children safe extends beyond the classroom and into extracurricular and recreational activities. With over 3.5 billion followers worldwide, soccer is…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 200-Patient Enrollment Milestone in Potentially Pivotal Berubicin Study
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced enrollment of 200 of the expected 243 patients in the company’s ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent Glioblastoma Multiforme (“GBM”), an aggressive…
Search Articles
Latest Articles
- MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) and Secarna Report Positive Early Results From Antibody Oligonucleotide Collaboration
- MissionIRNewsBreaks – Residential Equity Strategy Gains New Context with TYTL’s Reg D Filing
- MissionIRNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Reports First S-K 1300 Indicated Resource, Hybrid Mining Estimate for Sarfartoq
- MissionIRNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on Expanding AI Infrastructure Investment
- VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase